BNP Paribas Financial Markets’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-859
| Closed | -$163 | – | 3370 |
|
|
2023
Q2 | $163 | Hold |
859
| – | – | ﹤0.01% | 3214 |
|
|
2023
Q1 | $292 | Sell |
859
-344
| -29% | -$117 | ﹤0.01% | 3114 |
|
|
2022
Q4 | $389 | Hold |
1,203
| – | – | ﹤0.01% | 3217 |
|
|
2022
Q3 | $499 | Sell |
1,203
-397
| -25% | -$165 | ﹤0.01% | 3804 |
|
|
2022
Q2 | $696 | Sell |
1,600
-100
| -6% | -$44 | ﹤0.01% | 3294 |
|
|
2022
Q1 | $2.14K | Hold |
1,700
| – | – | ﹤0.01% | 3330 |
|
|
2021
Q4 | $2.21K | Buy |
1,700
+3
| +0.2% | +$4 | ﹤0.01% | 3336 |
|
|
2021
Q3 | $3.5K | Sell |
1,697
-500
| -23% | -$1.03K | ﹤0.01% | 3139 |
|
|
2021
Q2 | $3.47K | Sell |
2,197
-3,947
| -64% | -$6.24K | ﹤0.01% | 3229 |
|
|
2021
Q1 | $13.6K | Sell |
6,144
-254
| -4% | -$564 | ﹤0.01% | 3230 |
|
|
2020
Q4 | $15.9K | Sell |
6,398
-2,683
| -30% | -$6.65K | ﹤0.01% | 3222 |
|
|
2020
Q3 | $22.3K | Buy |
9,081
+7,592
| +510% | +$18.7K | ﹤0.01% | 3172 |
|
|
2020
Q2 | $5.29K | Buy |
1,489
+1,304
| +705% | +$4.63K | ﹤0.01% | 3353 |
|
|
2020
Q1 | $433 | Hold |
185
| – | – | ﹤0.01% | 3534 |
|
|
2019
Q4 | $407 | Sell |
185
-3,470
| -95% | -$7.63K | ﹤0.01% | 3593 |
|
|
2019
Q3 | $6.73K | Hold |
3,655
| – | – | ﹤0.01% | 3579 |
|
|
2019
Q2 | $5.3K | Sell |
3,655
-3,179
| -47% | -$4.61K | ﹤0.01% | 3610 |
|
|
2019
Q1 | $13.5K | Buy |
6,834
+6,003
| +722% | +$11.8K | ﹤0.01% | 3392 |
|
|
2018
Q4 | $1.09K | Sell |
831
-1,226
| -60% | -$1.61K | ﹤0.01% | 3229 |
|
|
2018
Q3 | $5.06K | Buy |
2,057
+480
| +30% | +$1.18K | ﹤0.01% | 3388 |
|
|
2018
Q2 | $5.3K | Sell |
1,577
-6,279
| -80% | -$21.1K | ﹤0.01% | 3425 |
|
|
2018
Q1 | $33.2K | Sell |
7,856
-196
| -2% | -$829 | ﹤0.01% | 3168 |
|
|
2017
Q4 | $26.6K | Buy |
8,052
+5,270
| +189% | +$17.4K | ﹤0.01% | 3236 |
|
|
2017
Q3 | $10.6K | Sell |
2,782
-206
| -7% | -$787 | ﹤0.01% | 3302 |
|
|
2017
Q2 | $13.1K | Buy |
+2,988
| New | +$13.1K | ﹤0.01% | 3306 |
|